Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |